| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,792 |
10,821 |
$2.41M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,720 |
7,362 |
$1.19M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,195 |
2,123 |
$777K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,949 |
1,826 |
$738K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,663 |
2,440 |
$714K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
9,399 |
2,394 |
$556K |
| 80053 |
Comprehensive metabolic panel |
26,175 |
22,617 |
$411K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
5,009 |
1,185 |
$367K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,264 |
6,249 |
$354K |
| G0378 |
Hospital observation service, per hour |
998 |
799 |
$352K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,347 |
2,598 |
$331K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,941 |
1,764 |
$320K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,479 |
4,953 |
$284K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,451 |
3,638 |
$214K |
| 71045 |
Radiologic examination, chest; single view |
4,157 |
3,723 |
$181K |
| 76000 |
|
1,388 |
1,268 |
$177K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,590 |
9,263 |
$170K |
| 71046 |
Radiologic examination, chest; 2 views |
3,106 |
2,877 |
$161K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,043 |
838 |
$156K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
555 |
518 |
$140K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,402 |
1,161 |
$137K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,743 |
2,962 |
$133K |
| 36415 |
Collection of venous blood by venipuncture |
33,327 |
27,861 |
$126K |
| 85027 |
|
16,106 |
14,075 |
$107K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,164 |
9,124 |
$102K |
| 80061 |
Lipid panel |
5,782 |
5,663 |
$93K |
| 83880 |
|
4,020 |
3,293 |
$90K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
748 |
736 |
$84K |
| 84484 |
|
5,013 |
3,877 |
$76K |
| 97597 |
|
959 |
143 |
$70K |
| 87400 |
|
2,191 |
1,824 |
$66K |
| 73562 |
|
786 |
744 |
$64K |
| 83690 |
|
5,185 |
4,692 |
$64K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
577 |
562 |
$61K |
| 96376 |
|
1,192 |
757 |
$57K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,617 |
1,567 |
$56K |
| 87581 |
|
1,673 |
1,621 |
$56K |
| 87486 |
|
1,673 |
1,621 |
$55K |
| 80305 |
|
2,682 |
2,499 |
$54K |
| 81001 |
|
8,621 |
7,944 |
$51K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
117 |
115 |
$48K |
| 84439 |
|
3,856 |
3,799 |
$48K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,786 |
4,688 |
$47K |
| 86140 |
|
5,153 |
4,657 |
$45K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,731 |
1,717 |
$43K |
| J3490 |
Unclassified drugs |
6,238 |
3,858 |
$43K |
| 72100 |
|
471 |
460 |
$42K |
| 64493 |
|
116 |
109 |
$40K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
6,615 |
5,742 |
$37K |
| 97161 |
|
1,160 |
1,100 |
$35K |
| 74022 |
|
398 |
386 |
$34K |
| 73030 |
|
421 |
389 |
$34K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,146 |
1,081 |
$32K |
| 83013 |
|
588 |
584 |
$32K |
| 73610 |
|
320 |
307 |
$32K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
34 |
27 |
$31K |
| 82553 |
|
2,308 |
1,817 |
$30K |
| 73630 |
|
459 |
438 |
$30K |
| 87071 |
|
1,623 |
1,586 |
$30K |
| 83874 |
|
2,187 |
1,717 |
$29K |
| J1610 |
Injection, glucagon hydrochloride, per 1 mg |
179 |
170 |
$29K |
| 83605 |
|
2,425 |
2,013 |
$28K |
| 87040 |
|
1,247 |
947 |
$27K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
291 |
193 |
$26K |
| 83735 |
|
3,824 |
3,268 |
$25K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,865 |
1,816 |
$25K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
391 |
381 |
$22K |
| 85610 |
|
4,368 |
3,715 |
$22K |
| 82150 |
|
1,972 |
1,785 |
$22K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
78 |
75 |
$22K |
| 81025 |
|
1,994 |
1,901 |
$22K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
251 |
242 |
$21K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,722 |
2,574 |
$21K |
| 80074 |
|
474 |
470 |
$21K |
| 73130 |
|
284 |
276 |
$21K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,382 |
1,208 |
$20K |
| 85730 |
|
3,058 |
2,736 |
$20K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
528 |
475 |
$20K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
608 |
596 |
$20K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
610 |
597 |
$20K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
113 |
110 |
$17K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
87 |
79 |
$17K |
| 85379 |
|
1,299 |
1,200 |
$15K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
105 |
104 |
$15K |
| 84403 |
|
623 |
617 |
$15K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,566 |
3,937 |
$15K |
| 64450 |
|
33 |
28 |
$14K |
| 84703 |
|
1,174 |
1,086 |
$13K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
333 |
122 |
$13K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
127 |
117 |
$12K |
| 82607 |
|
739 |
735 |
$11K |
| 84481 |
|
587 |
582 |
$10K |
| 87186 |
|
932 |
898 |
$10K |
| 82043 |
|
1,164 |
1,135 |
$10K |
| 95992 |
|
436 |
404 |
$10K |
| 82670 |
|
348 |
342 |
$10K |
| 64494 |
|
76 |
70 |
$10K |
| 80320 |
|
614 |
534 |
$9K |
| 86703 |
|
614 |
612 |
$9K |
| 86235 |
|
72 |
72 |
$9K |
| 85652 |
|
1,343 |
1,278 |
$8K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
16 |
16 |
$7K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
213 |
210 |
$7K |
| 83001 |
|
378 |
375 |
$7K |
| 86376 |
|
468 |
463 |
$6K |
| 62323 |
|
16 |
15 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,587 |
2,223 |
$6K |
| 83525 |
|
415 |
411 |
$6K |
| 82728 |
|
394 |
390 |
$6K |
| 64495 |
|
44 |
43 |
$5K |
| 73110 |
|
85 |
82 |
$5K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,327 |
1,891 |
$5K |
| 73502 |
|
105 |
97 |
$5K |
| 82570 |
|
827 |
812 |
$5K |
| 76536 |
|
45 |
44 |
$4K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,408 |
1,275 |
$4K |
| 87428 |
|
61 |
61 |
$4K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
12 |
12 |
$4K |
| 88312 |
|
53 |
53 |
$4K |
| J7050 |
Infusion, normal saline solution, 250 cc |
958 |
559 |
$4K |
| 83540 |
|
524 |
519 |
$4K |
| 82550 |
|
532 |
467 |
$4K |
| 87807 |
|
148 |
147 |
$4K |
| 83550 |
|
374 |
373 |
$4K |
| 94762 |
|
65 |
52 |
$4K |
| 74178 |
|
15 |
12 |
$4K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
1,779 |
1,198 |
$4K |
| 87077 |
|
386 |
366 |
$3K |
| 74019 |
|
31 |
29 |
$3K |
| 86592 |
|
449 |
444 |
$3K |
| 87507 |
|
245 |
234 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,105 |
747 |
$3K |
| 72110 |
|
28 |
28 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
954 |
796 |
$2K |
| 86677 |
|
112 |
109 |
$2K |
| 82805 |
|
43 |
37 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
888 |
793 |
$2K |
| 97032 |
|
115 |
39 |
$2K |
| 80329 |
|
113 |
108 |
$1K |
| 84153 |
|
87 |
86 |
$1K |
| 86000 |
|
37 |
37 |
$1K |
| 86780 |
|
91 |
90 |
$1K |
| 83014 |
|
116 |
115 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
414 |
357 |
$1K |
| 80143 |
|
45 |
44 |
$1K |
| 84550 |
|
179 |
176 |
$1K |
| 80327 |
|
86 |
80 |
$1K |
| 86225 |
|
73 |
73 |
$1K |
| 86038 |
|
81 |
80 |
$940.51 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
228 |
224 |
$929.48 |
| 86431 |
|
119 |
117 |
$892.29 |
| 82948 |
|
139 |
102 |
$871.71 |
| 73080 |
|
12 |
12 |
$752.11 |
| 96367 |
|
13 |
12 |
$667.99 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
26 |
25 |
$652.64 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
421 |
335 |
$604.92 |
| 84402 |
|
26 |
26 |
$596.06 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
286 |
211 |
$589.81 |
| 83655 |
|
39 |
39 |
$579.22 |
| 74018 |
|
14 |
14 |
$576.77 |
| 99001 |
|
123 |
118 |
$537.45 |
| 86200 |
|
38 |
37 |
$510.89 |
| J2060 |
Injection, lorazepam, 2 mg |
197 |
152 |
$508.06 |
| 84480 |
|
24 |
24 |
$440.54 |
| 84436 |
|
60 |
60 |
$399.79 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
18 |
18 |
$352.58 |
| 82274 |
|
24 |
24 |
$344.52 |
| 87338 |
|
25 |
25 |
$329.26 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
129 |
97 |
$297.20 |
| 82746 |
|
24 |
24 |
$292.58 |
| 90715 |
|
26 |
25 |
$235.21 |
| J1815 |
Injection, insulin, per 5 units |
43 |
25 |
$231.02 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
77 |
65 |
$221.73 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
14 |
13 |
$207.35 |
| 84100 |
|
38 |
37 |
$194.89 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
65 |
40 |
$194.82 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
33 |
28 |
$190.77 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
33 |
25 |
$169.78 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
124 |
79 |
$169.37 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
78 |
74 |
$162.87 |
| 87210 |
|
24 |
24 |
$160.38 |
| 77003 |
|
266 |
229 |
$160.22 |
| J3480 |
Injection, potassium chloride, per 2 meq |
44 |
39 |
$155.46 |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
42 |
32 |
$141.15 |
| A9270 |
Non-covered item or service |
140 |
94 |
$130.15 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
49 |
38 |
$128.87 |
| 86706 |
|
13 |
13 |
$120.61 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
90 |
78 |
$117.25 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
25 |
12 |
$103.38 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
32 |
27 |
$89.18 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
68 |
46 |
$50.92 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
33 |
30 |
$42.29 |
| A4331 |
Extension drainage tubing, any type, any length, with connector/adaptor, for use with urinary leg bag or urostomy pouch, each |
14 |
14 |
$40.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
21 |
15 |
$35.85 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
14 |
12 |
$35.84 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
86 |
70 |
$30.28 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
27 |
26 |
$30.18 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
23 |
13 |
$21.79 |
| G8991 |
Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
15 |
13 |
$0.00 |
| G8990 |
Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals |
13 |
13 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
104 |
81 |
$0.00 |